PGE(2) production after angiotensin-converting enzyme inhibition

被引:7
作者
Johnsen, SA [1 ]
Persson, IB [1 ]
Aurell, M [1 ]
机构
[1] GOTHENBURG UNIV,SAHLGRENSKA SJUKHUSET,DEPT NEPHROL,S-41345 GOTHENBURG,SWEDEN
来源
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY | 1997年 / 31卷 / 01期
关键词
ACE inhibition; angiotensin II; bradykinin; indomethacin; prostaglandin; lymphocyte proliferation;
D O I
10.3109/00365599709070307
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Using OKT3 monoclonal antibody driven T-lymphocyte proliferation, we investigated the effects of plasma 10, 20 and 30% in cell cultures on the proliferation ex vivo after exposure to captopril or enalapril taken orally by healthy volunteers. We also studied the effects of captopril, angiotensin II and bradykinin in vitro. We observed a plasma dependent dual effect of ACE inhibition both ex vivo and in vitro and of bradykinin in vitro being a stimulated proliferation at low (10% plasma) and a suppression of proliferation at high (30% plasma). The suppression was shown to be PGE(2) mediated but the nature of the stimulatory signal is unknown. Proliferation was also suppressed by angiotensin II mediated by PGE(2), but angiotensin II had no stimulatory effect. The results indicate that the effects of ACE inhibition on OKT3 mAb driven T-lymphocyte proliferation is plasma dependent, class specific for ACE inhibitors and mediated by both the ACE inhibitor itself and by bradykinin. Furthermore, it was shown that indomethacin in combination with an ACE inhibitor or bradykinin converted a suppressive response into proliferation indicating an immunostimulatory activity by indomethacin.
引用
收藏
页码:81 / 88
页数:8
相关论文
共 38 条
[1]   EFFECTS OF CAPTOPRIL ON ATHEROSCLEROSIS IN CYNOMOLGUS MONKEYS [J].
ABERG, G ;
FERRER, P .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 15 :S65-S72
[2]   INCREASED SURVIVAL OF CANCER-BEARING MICE TREATED WITH INHIBITORS OF PROSTAGLANDIN SYNTHESIS ALONE OR WITH CHEMOTHERAPY [J].
BENNETT, A ;
BERSTOCK, DA ;
CARROLL, MA .
BRITISH JOURNAL OF CANCER, 1982, 45 (05) :762-768
[3]   ATHEROSCLEROSIS - BASIC MECHANISMS - OXIDATION, INFLAMMATION, AND GENETICS [J].
BERLINER, JA ;
NAVAB, M ;
FOGELMAN, AM ;
FRANK, JS ;
DEMER, LL ;
EDWARDS, PA ;
WATSON, AD ;
LUSIS, AJ .
CIRCULATION, 1995, 91 (09) :2488-2496
[4]   REVERSIBLE MEMBRANOUS NEPHRITIS ASSOCIATED WITH DICLOFENAC [J].
CAMPISTOL, JM ;
GALOFRE, J ;
BOTEY, A ;
TORRAS, A ;
REVERT, L .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1989, 4 (05) :393-395
[5]   ANGIOTENSIN-I-CONVERTING ENZYME IN HUMAN CIRCULATING MONONUCLEAR-CELLS - GENETIC-POLYMORPHISM OF EXPRESSION IN LYMPHOCYTES-T [J].
COSTEROUSSE, O ;
ALLEGRINI, J ;
LOPEZ, M ;
ALHENCGELAS, F .
BIOCHEMICAL JOURNAL, 1993, 290 :33-40
[6]   IMPAIRMENT OF GRANULOMATOUS INFLAMMATORY RESPONSE TO HISTOPLASMA-CAPSULATUM BY INHIBITORS OF ANGIOTENSIN-CONVERTING ENZYME [J].
DEEPE, GS ;
TAYLOR, CL ;
SRIVASTAVA, L ;
BULLOCK, WE .
INFECTION AND IMMUNITY, 1985, 48 (02) :395-401
[7]   CAPTOPRIL AND IMMUNE REGULATION [J].
DELFRAISSY, JF ;
GALANAUD, P ;
BALAVOINE, JF ;
WALLON, C ;
DORMONT, J .
KIDNEY INTERNATIONAL, 1984, 25 (06) :925-929
[8]   PHARMACOKINETICS OF CAPTOPRIL IN HEALTHY-SUBJECTS AND IN PATIENTS WITH CARDIOVASCULAR-DISEASES [J].
DUCHIN, KL ;
MCKINSTRY, DN ;
COHEN, AI ;
MIGDALOF, BH .
CLINICAL PHARMACOKINETICS, 1988, 14 (04) :241-259
[9]   KININS MEDIATE THE ANTIPROLIFERATIVE EFFECT OF RAMIPRIL IN RAT CAROTID-ARTERY [J].
FARHY, RD ;
HO, KL ;
CARRETERO, OA ;
SCICLI, AG .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 182 (01) :283-288
[10]   DISAPPEARANCE OF BRADYKININ AND ELEDOISIN IN CIRCULATION AND VASCULAR BEDS OF CAT [J].
FERREIRA, SH ;
VANE, JR .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1967, 30 (02) :417-&